SINT · Sintx Technologies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.02M | $2.89M | $2.63M | $1.56M | $606.0K | $594.0K |
| Cost of Revenue | $557.0K | $811.0K | $784.0K | $265.0K | $449.0K | $475.0K |
| Gross Profit | $461.0K | $2.08M | $1.84M | $1.30M | $157.0K | $119.0K |
| R&D | $4.59M | $5.20M | $8.71M | $6.45M | $5.89M | $4.81M |
| SG&A | $6.20M | $4.00M | $4.22M | $3.99M | $3.60M | $3.13M |
| Total Operating Expenses | $11.18M | $16.12M | $15.20M | $12.63M | $10.78M | $8.62M |
| D&A | $319.0K | $842.0K | $907.0K | $335.0K | $185.0K | $78.0K |
| Operating Income | ($10.72M) | ($14.05M) | ($13.36M) | ($11.34M) | ($10.62M) | ($8.50M) |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - |
| Net Income | ($10.36M) | ($11.02M) | ($8.26M) | ($12.04M) | ($8.78M) | ($7.03M) |
| EPS - Basic | ($6.16) | ($14.87) | ($444.00) | ($10934.00) | ($7200.00) | ($20200.00) |
| EPS - Diluted | ($6.16) | ($15.19) | ($626.00) | ($12162.00) | ($7600.00) | ($21600.00) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.14M | $3.60M | $3.34M | $6.25M | $14.27M | $25.35M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | $825.0K | $502.0K | $1.22M | $737.0K | $597.0K | $487.0K |
| Accounts Payable | $382.0K | $299.0K | $636.0K | $434.0K | $217.0K | $194.0K |
| Current Assets | $5.65M | $4.77M | $5.53M | $7.21M | $15.03M | $27.59M |
| Total Assets | $9.51M | $9.41M | $15.37M | $15.77M | $21.84M | $30.45M |
| Current Liabilities | $3.73M | $1.98M | $2.91M | $8.08M | $2.21M | $2.88M |
| Long-term Debt | - | - | - | $368.0K | - | $287.0K |
| Total Liabilities | $6.58M | $5.52M | $6.59M | $10.07M | $4.11M | $4.64M |
| Stockholders' Equity | $2.93M | $3.89M | $8.77M | $5.70M | $17.73M | $25.80M |
| Retained Earnings | ($292.10M) | ($281.74M) | ($270.71M) | ($262.45M) | ($249.88M) | ($241.11M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($8.57M) | ($8.64M) | ($14.12M) | ($10.26M) | ($10.13M) | ($9.11M) |
| Investing Cash Flow | $913.0K | ($194.0K) | ($501.0K) | ($1.10M) | ($1.65M) | $1.75M |
| Financing Cash Flow | $8.20M | $9.09M | $11.71M | $3.34M | $705.0K | $30.93M |
| CapEx | $185.0K | $690.0K | $530.0K | $1.41M | $3.74M | $360.0K |
| Free Cash Flow | ($8.76M) | ($9.33M) | ($14.64M) | ($11.67M) | ($13.87M) | ($9.47M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 45.3% | 71.9% | 70.2% | 83.0% | 25.9% | 20.0% |
| Operating margin | -1053.1% | -486.6% | -508.5% | -726.1% | -1752.5% | -1431.6% |
| EBITDA margin | -1021.8% | -457.4% | -474.0% | -704.7% | -1721.9% | -1418.5% |
| Net margin | -1018.1% | -381.8% | -314.4% | -771.2% | -1448.0% | -1183.3% |
| Free cash flow margin | -860.1% | -323.2% | -557.5% | -747.5% | -2288.9% | -1594.6% |
| FCF / Net income | 0.84 | 0.85 | 1.77 | 0.97 | 1.58 | 1.35 |
| R&D / Revenue | 450.6% | 180.2% | 331.7% | 413.2% | 971.3% | 809.4% |
| SG&A / Revenue | 608.7% | 138.4% | 160.7% | 255.6% | 594.6% | 527.3% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -109.0% | -117.1% | -53.8% | -76.3% | -40.2% | -23.1% |
| Return on equity | -353.8% | -283.1% | -94.2% | -211.1% | -49.5% | -27.2% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.51 | 2.41 | 1.90 | 0.89 | 6.79 | 9.58 |
| Quick ratio | 1.29 | 2.15 | 1.48 | 0.80 | 6.52 | 9.41 |
| Cash ratio | 1.11 | 1.82 | 1.15 | 0.77 | 6.45 | 8.81 |
| Leverage | ||||||
| Debt / Equity | - | - | - | 0.06 | - | 0.01 |
| Debt / Assets | - | - | - | 0.02 | - | 0.01 |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 3.25 | 2.42 | 1.75 | 2.77 | 1.23 | 1.18 |
| Liabilities / Assets | 0.69 | 0.59 | 0.43 | 0.64 | 0.19 | 0.15 |
| Efficiency | ||||||
| Asset turnover | 0.11 | 0.31 | 0.17 | 0.10 | 0.03 | 0.02 |
| Inventory turnover | 0.68 | 1.62 | 0.64 | 0.36 | 0.75 | 0.98 |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | 541d | 226d | 568d | 1015d | 485d | 374d |
| Days payable outstanding | 250d | 135d | 296d | 598d | 176d | 149d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | 3.7x | 0.7x | 37.9x | 107.7x | 18157.7x | 21229.6x |
| P / S | 10.5x | 0.9x | 126.4x | 393.6x | 531188.1x | 922237.5x |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -64.7% | 9.9% | 68.3% | 157.6% | 2.0% | -13.8% |
| Revenue CAGR (3y) | -13.3% | 68.3% | 64.1% | 31.3% | 85.5% | -62.5% |
| Revenue CAGR (5y) | 11.4% | 33.2% | 94.2% | -32.6% | -47.5% | -50.2% |
| Gross profit growth (YoY) | -77.8% | 12.6% | 42.2% | 725.5% | 31.9% | -13.8% |
| Operating income growth (YoY) | 23.7% | -5.2% | -17.8% | -6.7% | -24.9% | -29.0% |
| Net income growth (YoY) | 6.0% | -33.5% | 31.4% | -37.2% | -24.8% | -46.5% |
| EPS growth (YoY) | 59.4% | 97.6% | 94.9% | -60.0% | 64.8% | -379513.4% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 6.2% | 36.3% | -25.5% | 15.9% | -46.4% | -43.9% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -24.8% | -55.6% | 53.8% | -67.8% | -31.3% | 396.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$1.02M totalProduct$729.0K · 71.6%
Grant And Contract$289.0K · 28.4%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
-29.09
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
2/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Sintx Technologies against the 5 most active filers in the same SIC group.